Published in Int J Cancer on June 30, 2014
Legalize marijuana without the smoke. CMAJ (2017) 1.39
An epidemiologic review of marijuana and cancer: an update. Cancer Epidemiol Biomarkers Prev (2015) 0.87
Legalizing Cannabis: A physician's primer on the pulmonary effects of marijuana. Curr Respir Care Rep (2014) 0.77
Vaporizer legalization. CMAJ (2014) 0.77
Cannabis Smoking in 2015: A Concern for Lung Health? Chest (2015) 0.76
Cannabis and Young Users-A Brief Intervention to Reduce Their Consumption (CANABIC): A Cluster Randomized Controlled Trial in Primary Care. Ann Fam Med (2017) 0.75
Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review. NPJ Prim Care Respir Med (2016) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science (1996) 5.17
Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med (2008) 4.01
Triggering myocardial infarction by marijuana. Circulation (2001) 3.36
Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29
Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med (1988) 2.72
The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med (2013) 2.36
Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst (1998) 2.34
Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2006) 2.32
Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest (1997) 2.28
Effects of cannabis on lung function: a population-based cohort study. Eur Respir J (2009) 2.16
Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis (1987) 2.16
Association between marijuana exposure and pulmonary function over 20 years. JAMA (2012) 2.09
An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J (2008) 1.97
A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol (2007) 1.94
Effects of cannabis on pulmonary structure, function and symptoms. Thorax (2007) 1.79
Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed) (1987) 1.75
Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol (2008) 1.74
Cardiovascular system effects of marijuana. J Clin Pharmacol (2002) 1.55
International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev (2008) 1.51
The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.47
Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol (2000) 1.44
Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control (2013) 1.42
Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am Rev Respir Dis (1987) 1.34
The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med (2006) 1.21
A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control (2002) 1.12
Marijuana use and cancer incidence (California, United States). Cancer Causes Control (1997) 1.04
Chronic inhalation of marijuana and tobacco in dogs: pulmonary pathology. Res Commun Chem Pathol Pharmacol (1976) 1.04
Risk of lung cancer and past use of cannabis in Tunisia. J Thorac Oncol (2006) 1.00
Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. South Med J (1988) 0.94
Mutagenic activity of marihuana smoke condensates. Cancer Lett (1979) 0.92
Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J Psychoactive Drugs (1995) 0.88
Marijuana. Its health hazards and therapeutic potentials. Council on Scientific Affairs. JAMA (1981) 0.79
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10
Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med (2014) 9.94
Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol (2011) 6.16
Estimating causal effects. Int J Epidemiol (2002) 6.08
Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99
Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell (2006) 5.72
A method to automate probabilistic sensitivity analyses of misclassified binary variables. Int J Epidemiol (2005) 5.17
Causation and causal inference in epidemiology. Am J Public Health (2005) 4.70
Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med (2013) 4.64
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
Frequency and clinical predictors of adverse reactions to chiropractic care in the UCLA neck pain study. Spine (Phila Pa 1976) (2005) 4.52
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Angiosarcoma. Lancet Oncol (2010) 4.34
Associations of race/ethnicity with HIV prevalence and HIV-related behaviors among young men who have sex with men in 7 urban centers in the United States. J Acquir Immune Defic Syndr (2004) 4.25
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med (2012) 3.52
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol (2010) 3.49
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18
Multiple-imputation for measurement-error correction. Int J Epidemiol (2006) 3.13
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol (2004) 2.93
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol (2006) 2.89
Heterogeneity of childhood asthma among Hispanic children: Puerto Rican children bear a disproportionate burden. Pediatrics (2006) 2.89
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet (2009) 2.76
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis (2008) 2.74
Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst (2004) 2.66
Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst (2009) 2.58
Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet (2008) 2.53
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol (2007) 2.52
Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis (2005) 2.47
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer (2011) 2.43
Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ (2010) 2.42
A randomized trial of medical care with and without physical therapy and chiropractic care with and without physical modalities for patients with low back pain: 6-month follow-up outcomes from the UCLA low back pain study. Spine (Phila Pa 1976) (2002) 2.40
A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol (2008) 2.39
Proper interpretation of non-differential misclassification effects: expectations vs observations. Int J Epidemiol (2005) 2.34
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial. Lancet Oncol (2012) 2.33
Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2006) 2.32
A randomized trial of chiropractic manipulation and mobilization for patients with neck pain: clinical outcomes from the UCLA neck-pain study. Am J Public Health (2002) 2.32
Socioeconomic status and childhood leukaemia: a review. Int J Epidemiol (2005) 2.30
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res (2005) 2.24
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr (2008) 2.22
Prediction of Barrett's esophagus among men. Am J Gastroenterol (2013) 2.22
Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol (2012) 2.21
Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer. Am J Epidemiol (2004) 2.18
HIV prevalence among foreign- and US-born clients of public STD clinics. Am J Public Health (2002) 2.17
Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol (2012) 2.16
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant (2005) 2.16
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol (2012) 2.15
Adverse reactions to chiropractic treatment and their effects on satisfaction and clinical outcomes among patients enrolled in the UCLA Neck Pain Study. J Manipulative Physiol Ther (2004) 2.11
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst (2005) 2.10
The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994-2004. N Z Med J (2008) 2.10
Risk factors, confounding, and the illusion of statistical control. Psychosom Med (2004) 2.09
Increased risk of serious injury following an initial prescription for diphenhydramine. Ann Allergy Asthma Immunol (2002) 2.07
Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol (2007) 2.05
Cytokine gene polymorphisms in heavy drinkers with and without decompensated liver disease: a case-control study. Am J Gastroenterol (2008) 2.00
The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol (2013) 1.99
Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals. Int J Epidemiol (2009) 1.97
Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol (2009) 1.97
Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet (2003) 1.94
VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. J Clin Oncol (2008) 1.94
Exposure-measurement error is frequently ignored when interpreting epidemiologic study results. Eur J Epidemiol (2006) 1.93
PRISM, a generic large scale proteomic investigation strategy for mammals. Mol Cell Proteomics (2003) 1.91
Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res (2004) 1.91
Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status. Am J Kidney Dis (2012) 1.91
Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2013) 1.90
Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharmacol (2002) 1.89
Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol (2009) 1.87
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res (2009) 1.84
The use of complementary and alternative medicine among california adults with and without cancer. Evid Based Complement Alternat Med (2005) 1.82
Cancer disparities in indigenous Polynesian populations: Māori, Native Hawaiians, and Pacific people. Lancet Oncol (2008) 1.81
Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension (2005) 1.80
Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res (2010) 1.79
Bayesian regression in SAS software. Int J Epidemiol (2012) 1.78
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet (2012) 1.77
Epidemiologic review of marijuana use and cancer risk. Alcohol (2005) 1.76
Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75
Canonical WNT/beta-catenin signaling is required for ureteric branching. Dev Biol (2008) 1.75
Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis (2011) 1.74
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors. Support Care Cancer (2013) 1.74
Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol (2013) 1.73
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Cancer Detect Prev (2007) 1.69
Splines for trend analysis and continuous confounder control. Epidemiology (2011) 1.69
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
Estimating bias from loss to follow-up in the Danish National Birth Cohort. Epidemiology (2011) 1.68
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67
Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer (2006) 1.65